Lavipharm S.A (LAVI) — Capital Reinvestment Ratio
Latest as of December 2022:
33.32x
Lavipharm S.A (LAVI) has a Capital Reinvestment Ratio of 33.32x as of December 2022, meaning it reinvests 33% of its operating cash flow (€527.00K) in capital expenditures (€17.56 Million). See LAVI free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
33.32x
Capex / Operating Cash Flow
Operating Cash Flow
€527.00K
EUR
Capital Expenditures
€17.56 Million
EUR
Data as of
Dec 2022
Most recent filing
Lavipharm S.A Capital Reinvestment Ratio (2014–2024)
This chart tracks Lavipharm S.A's Capital Reinvestment Ratio across 11 annual periods.
Annual Capital Reinvestment Ratio for Lavipharm S.A (2014–2024)
Year-by-year Capital Reinvestment Ratio for Lavipharm S.A from 2014 to 2024. For live market cap and broader valuation context, see Lavipharm S.A market capitalisation.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 2.08x | €4.64 Million | €9.64 Million | ▼ -85.4% |
| 2023 | 14.26x | €284.00K | €4.05 Million | ▲ +34.0% |
| 2022 | 10.64x | €3.35 Million | €35.62 Million | ▲ +2020.0% |
| 2021 | 0.50x | €3.82 Million | €1.92 Million | ▼ -3.1% |
| 2020 | 0.52x | €2.85 Million | €1.48 Million | ▼ -38.0% |
| 2019 | 0.84x | €2.89 Million | €2.42 Million | ▲ +14.7% |
| 2018 | 0.73x | €1.42 Million | €1.03 Million | ▲ +215.0% |
| 2017 | 0.23x | €1.51 Million | €350.00K | ▲ +44.4% |
| 2016 | 0.16x | €606.00K | €97.00K | ▲ +300.9% |
| 2015 | 0.04x | €576.00K | €23.00K | ▼ -92.1% |
| 2014 | 0.51x | €2.38 Million | €1.20 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow